About 4Tissue
4Tissue is a biotech company at the forefront of regenerative medicine, utilizing advanced bio-interactive hydrogels to transition from cells to tissue engineering. Founded through a collaboration between Prof. Phillip Blondeel, a global leader in plastic and reconstructive surgery, and Prof. Dr. Sandra Van Vlierberghe, an expert in polymer chemistry, 4Tissue is a spin-off from Ghent University (UGent), Ghent University Hospital (UZGent), and the Vrije Universiteit Brussel (VUB). The company develops natural and minimally invasive treatments for tissue reconstruction and regeneration, with applications in different medical fields. By harnessing cutting-edge science and a multidisciplinary team of experts, 4Tissue aims to shape the future of regenerative medicine and improve patient outcomes worldwide. Other founders include Dr. An Van Den Bulcke (COO), Dr. Lana Van Damme (CSO), and Bernard Depypere, MD.
- Founding: 2023
- Focus : Manufacturer
- Employees: 1-10
- Industry : Biotechnology, Healthcare